Lv62
2790 积分 2024-07-22 加入
Inducible IL-12 or IL-18 secreting CAR T cells targeting the glyco-antigen CD176 exhibit potent activity against non-small cell lung cancer in preclinical models
17天前
已完结
CD19 CAR T-cell Escape in Large B-cell Lymphoma: Antigen Density Matters after All
17天前
已完结
Cellular and molecular mechanisms determining allogeneic CAR T cell rejection and expansion
18天前
已完结
Safety and Efficacy of AZD0120, a BCMA/CD19 Dual-Targeting CAR T-cell Therapy, in relapsed/refractory Multiple Myeloma: Preliminary Results from the DURGA-1 phase 1b/2 Study
18天前
已完结
In vivo engineering of CAR natural killer cells for immunotherapy using ligand-directed lipid nanoparticles
21天前
已完结
Extended follow-up of in vivo BCMA CAR-T therapy in relapsed/refractory multiple myeloma
26天前
已完结
In vivo CAR‑T cell therapy: mechanisms, clinical advances and optimization strategies
26天前
已完结
Quantitative Characterization of Innate and Adaptive Pharmacology of Allogeneic anti-CD20 Chimeric Antigen Receptor (CAR) Vδ1 γδ T cells using Multiscale Mechanistic Modeling
1个月前
已完结
Comparison of the safety profiles of CD19-targeting CAR T-cell therapy in patients with SLE and B-cell lymphoma
1个月前
已完结
IL-21 boosts T cell-therapy efficacy for solid tumors by enhancing mitochondrial Ca2+-mediated motility of effector CD8+ T cells
1个月前
已完结
皖公网安备34019202002308
